A Dialogue with Injection Drug Users: Their Perspectives on Behavior Change for HIV Prevention. FHI, USAID and Vietnamese and Americans in Partnership to Fight HIV/AIDS (2007)

A Dialogue with Injection Drug Users: Their Perspectives on Behavior Change for HIV Prevention. USAID, FHI and Vietnamese and Americans in Partnership to Fight HIV/AIDS (2007) The 2005-2006 Integrated Biological and Behavioral Surveillance (IBBS) survey suggested that high-risk behaviors persist among injection drug users (IDUs) and that HIV prevention programs in some areas were limited in reach. Key areas identified by IBBS as needing improvement included

Download this publication

Association between Expatriation and HIV Awareness and Knowledge among Injecting Drug Users in Kabul, Afghanistan: A Cross-Sectional Comparison of Former Refugees to Those Remaining During Conflict. Todd CS, Abed AMS, Strathdee SA, et al (2007)

Association between Expatriation and HIV Awareness and Knowledge among Injecting Drug Users in Kabul, Afghanistan: A Cross-Sectional Comparison of Former Refugees to Those Remaining During Conflict. Todd CS, Abed AMS, Strathdee SA, et al (2007)

Little is known about human immunodeficiency virus (HIV) awareness among Afghan injecting drug users (IDUs), many of whom initiated injecting as refugees. We explored whether differences in HIV awareness and knowledge exist between Afghan IDUs who were refugees compared to those never having left Afghanistan.


Download this publication

Deadly Denial: Barriers to HIV/AIDS Treatment for People who Use Drugs in Thailand. Human Rights Watch and Thai AIDS Treatment Action Group (2007)

Deadly Denial: Barriers to HIV/AIDS Treatment for People who Use Drugs in Thailand. Human Rights Watch and Thai AIDS Treatment Action Group (2007) Thailand is one of the few developing countries to have successfully curbed a runaway HIV/AIDS epidemic, cutting the number of new infections by almost 80 percent since 1991. Among injection drug users, however, prevalence has not dropped, and remains at nearly 50 percent—virtually unchanged over the past two decades.

Download this publication

Differences in the Social Networks of Ethnic Vietnamese and Non-Vietnamese Injecting Drug Users and Their Implications for Blood-borne Virus Transmission. Aitken CK, Higgs P and Bowden S (2007)

cover-coming-soon

The social networks of 49 ethnic Vietnamese injecting drug users (IDUs) and 150 IDUs of other ethnicities recruited in Melbourne, Australia, were examined for ethnic differences in distribution of hepatitis C virus infection risk using social network analysis and molecular epidemiology. Vietnamese IDUs were more highly connected than non-Vietnamese IDUs, and more likely to be members of dense injecting sub-networks.


Download this publication

Harm Reduction in Asia: No More Time to Wait. Kamarulzaman, A (2007)

Harm Reduction in Asia: No More Time to Wait. Kamarulzaman, A (2007) Harm Reduction in Asia No More Time To Wait Adeeba Kamarulzaman Malaysian AIDS Council University Malaya Medical Centre

Download this publication

HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan. Todd CS, Abed AMS, Strathdee SA, et al (2007)

HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan. Todd CS, Abed AMS, Strathdee SA, et al (2007) Limited prevalence data for HIV, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) exist for Afghanistan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006. Study participants completed interviewer-administered questionnaires and underwent testing for HIV, antibody to HCV, and HBsAg

Download this publication

Integrated Biological- Behavioral Surveillance among Most-at-Risk Groups in Indonesia, 2007: Surveillance Highlights- Injecting Drug Users. Department of Health, Statistics Indonesia, USAID, et al. (2007)

Integrated Biological- Behavioral Surveillance among Most-at-Risk Groups in Indonesia, 2007: Surveillance Highlights- Injecting Drug Users. The Department of Health Indonesia, The National AIDS Commission, Komisi Penanggulangan AIDS, et al (2007) Injecting drug users (IDU) are particularly vulnerable to transmission of HIV because sharing contaminated drug injecting equipment transmits the HIV virus more efficiently thananyothermodeoftransmission. Sinceinitialdataindicating19%prevalenceamong IDU in 1999, HIV prevalence has been consistently rising in this population sub-group. and represents the highest prevalence of HIV among identifiable population sub-groups in Indonesia. This summary presents key findings of the IBBS 2007 from two (2) cities from which only behavioral survey data were gathered (Semarang and Malang) and four (4) cities from which both biological and behavioral data were gathered (Medan, Jakarta, Bandung, and Surabaya). Official estimates for 2006 indicated there were 190,000 - 248,000 IDU in Indonesia in that year.

Download this publication

Maldives Drug Control Master Plan 2006-2010. National Narcotics Control Bureau and UNODC (2007)

Maldives Drug Control Master Plan 2006-2010. National Narcotics Control Bureau and UNODC (2007) Drug abuse is a complex and multifaceted problem facing the whole nation, cutting across all age groups and social strata. Hardly a community or a family is free from its harm- ful effects. In 2003, a Rapid Situation Assessment (RSA) revealed the seriousness of the situation and prompted the elaboration of this national master plan for drug control. Based on in- formation from about 4,000 individuals, the RSA revealed that the most common drugs of initiation were heroin (43%) and cannabinoids (34%). The most commonly abused drug during the month preceding the survey were opioids (76%) and cannabinoids (12%).

Download this publication

Novel Heroin Injection Practices: Implications for Transmission of HIV and other Bloodborne Pathogens. Clatts MC, Giang LM, Goldsamt LA, et al (2007)

cover-coming-soon

Rapid expansion in local heroin markets in Southeast and Southern Asia—including China, Vietnam, Thailand, Laos, Myanmar, and India—has been paralleled by rapid increases in negative medical consequences associated with high-risk heroin injection practices.


Download this publication

Prevention of Transmission of HIV among Drug Users in SAARC Countries : Legal and Policy Concerns Related to IDU Harm Reduction in SAARC Countries. UNODC, DFID and AUSAID (2007)

Prevention of Transmission of HIV among Drug Users in SAARC Countries : Legal and Policy Concerns Related to IDU Harm Reduction in SAARC Countries. UNODC, DFID and AUSAID (2007) In the last two decades, countries belonging to the SAARC (South Asian Association for Regional Cooperation) region have seen a dramatic increase in the prevalence of HIV and of injecting drug use. As a result, HIV/AIDS control authorities have implemented harm reduction measures including condom promotion and needle syringe exchange. In view of the positive international experience and some success in countries in South Asia, a need was felt to replicate and expand harm reduction measures. A question has naturally arisen whether these measures are within the bounds of national laws or whether the national laws hinder them and, if so, what can be done about them. This is the broad focus of this document.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Jul
11
(11 Jul - 11 Jul)
Jul
28
(28 Jul - 28 Jul)